Publication | February 2020
Authors: Kevin Harnisch, Andrew Price, James Bateson and Patrick Doyle with Norton Rose Fulbright; and David Ho and Nepomuk Loesti with American International Group, Inc.
A recent decision from a US appellate court may change the way that non-US companies view the sale of their securities in the US. That case, Stoyas v. Toshiba Corp., found that a foreign issuer could be liable under US securities laws for a sale of its securities in the US, even if the company was not involved in the sale. This creates real risk for publicly-traded, non-US companies.
In the full white paper, we discuss:
As businesses worldwide navigate the challenges brought on by the rapid spread of COVID-19 (coronavirus), it is now more essential than ever that corporations be ready with solutions to address risk issues as they arise.
The economic effects of the outbreak of coronavirus (COVID-19) for many businesses are significant and likely to endure for a long period of time.
In a further response to the COVID-19 (coronavirus) crisis, the European Central Bank (ECB) has launched a €750 billion Pandemic Emergency Purchase Program (PEPP), a new temporary asset purchase program of private and public sector securities, which will last until at least the end of 2020.
Subscribe and stay up to date with the latest legal news, information and events...
